MedTrace Logo

Injectable Contraception Cohort Study in Punjab, Pakistan

NCT05774626 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1009

Last updated 2025-07-22

No results posted yet for this study

Summary

The aim of this study is to assess the value proposition of expanding contraceptive options available to women in Punjab, Pakistan to include subcutaneous depot medroxyprogesterone acetate (DMPA-SC).

Specific objectives are:

1. To compare 12-month continuation rates for DMPA-SC and intramuscular DMPA (DMPA-IM) among married women 18- 49 years of age in two districts of Punjab, Pakistan
2. To understand how characteristics and experiences of DMPA-SC and DMPA-IM users differ.
3. To assess how well women opting for self-injection of DMPA-SC adhere to standards for commodity storage, injection timing, injection technique, and waste disposal

Conditions

  • Contraceptive Usage

Interventions

BEHAVIORAL

Contraceptive usage

Continued use of injectable contraception, administered on a quarterly basis

Sponsors & Collaborators

  • Jhpiego

    lead OTHER

Principal Investigators

  • Hannah Tappis, DrPH · Jhpiego

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-18
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05774626 on ClinicalTrials.gov